Sector
PharmaceuticalsOpen
₹8Prev. Close
₹8Turnover(Lac.)
₹0Day's High
₹8Day's Low
₹852 Week's High
₹052 Week's Low
₹0Book Value
₹-17.4Face Value
₹10Mkt Cap (₹ Cr.)
4.13P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Equity Capital | 5.16 | 5.16 | 5.16 | 5.16 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -10.85 | -10.74 | -23.51 | -21.29 |
Net Worth | -5.69 | -5.58 | -18.35 | -16.13 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | 0 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | 0 | 0 | 0 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Profit before tax | -0.1 | -0.14 | -0.24 | -0.16 |
Depreciation | -0.02 | -0.03 | -0.04 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.01 | -0.01 | -0.01 | -0.02 |
Other operating items |
| Y/e 31 Mar | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | 0 |
Op profit growth | -25.87 | -46.54 | 21.98 | -58.81 |
EBIT growth | -26.21 | -43.04 | 47.17 | -58.81 |
Net profit growth | -26.21 | -91.87 | 930.62 | -58.79 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,678.3 | 94.02 | 4,02,680.39 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,612.15 | 79.46 | 1,75,531.81 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,464.85 | 24.02 | 1,18,307.2 | 1,485.4 | 1.09 | 4,254.47 | 397.44 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,173.95 | 56.38 | 1,07,416.07 | 474 | 1.01 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,251.75 | 19.53 | 1,04,452.95 | 1,200.7 | 0.64 | 5,546.3 | 345.81 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Director
Ramesh Haridass
Director
Urvashi Ramesh
Independent Director
Rajath Patankar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by New Heaven Chemicals & Industries Ltd
Summary
No Record Found
Read More
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.